LISTERINE AND CHECK-UP "AT RISK" OF REGULATORY ACTION FOR ANTI-PLAQUE, GINGIVITIS CLAIMS, FDA TELLS MARKETERS; LETTERS TO OTHER FIRMS TO FOLLOW

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".